Anavex Life Sciences Corp (AVXL)

[falconer66a]

Looks favorable for Rett Syndrome

Thanks for the URL.

If the molecule (or analogues) work in afflicted humans as described, the drug looks to be very useful.

Appears that it will work best if administered early on, with Rett Syndrome right at birth, as the drug appears to best treat things during development. Therapeutic efficacy at later ages, when neurons and brain tissues are more developed, may be questionable.

The drug is certainly not a competitor of Anavex 2-73. It works very differently, affecting certain neuron molecules (cytokines, etc.).

One form of the molecule apparently can cross the blood/brain barrier (it can be orally administered). It also is claimed to have a longer half-life (resides in cells longer). All favorable.

But actual therapeutic outcomes, degree of healing, is not mentioned (and presently may not be known).

Hope this can work for Rett Syndrome patients. (I'll still restrict my investments to AVXL.)